99
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Role of toll-like receptors gene polymorphism in hepatocellular carcinoma

, , , &
Pages 345-347 | Received 17 Feb 2014, Accepted 08 Mar 2014, Published online: 18 Mar 2014

References

  • Wang CM, Chang SW, Wu YJ, et al. Genetic variations in toll-like receptors (tlrs 3/7/8) are associated with systemic lupus erythematosus in a taiwanese population. Sci Rep 2014;4:3792
  • Lee BL, Barton GM. Trafficking of endosomal toll-like receptors. Trends Cell Biol 2014. [Epub ahead of print]
  • Uemura M, Sasaki Y, Yamada T, et al. Serum antibody titers against hepatitis c virus and postoperative intrahepatic recurrence of hepatocellular carcinoma. Ann Surg Oncol 2014. [Epub ahead of print]
  • Zhou TB. Role of toll-like receptors gene polymorphism in renal transplantation. J Recept Signal Transduct Res 2014;34:12–4
  • Shuto T. [Regulation of expression, function, and inflammatory responses of innate immune receptor toll-like receptor-2 (tlr2) during inflammatory responses against infection]. Yakugaku Zasshi 2013;133:1401–9
  • Nischalke HD, Coenen M, Berger C, et al. The toll-like receptor 2 (tlr2)-196 to-174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis c. Int J Cancer 2012;130:1470–5
  • Junjie X, Songyao J, Minmin S, et al. The association between toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility. BMC Cancer 2012;12:57
  • Naumann K, Wehner R, Schwarze A, et al. Activation of dendritic cells by the novel toll-like receptor 3 agonist rgc100. Clin Dev Immunol 2013;2013:283649
  • Gorbea C, Rechsteiner M, Vallejo JG, Bowles NE. Depletion of the 26s proteasome adaptor ecm29 increases toll-like receptor 3 signaling. Sci Signal 2013;6:ra86
  • Li G, Zheng Z. Toll-like receptor 3 genetic variants and susceptibility to hepatocellular carcinoma and hbv-related hepatocellular carcinoma. Tumour Biol 2013;34:1589–94
  • Al-Qahtani A, Al-Ahdal M, Abdo A, et al. Toll-like receptor 3 polymorphism and its association with hepatitis b virus infection in saudi arabian patients. J Med Virol 2012;84:1353–9
  • Minmin S, Xiaoqian X, Hao C, et al. Single nucleotide polymorphisms of toll-like receptor 4 decrease the risk of development of hepatocellular carcinoma. PLoS One 2011;6:e19466
  • Agúndez JA, Garcia-Martin E, Devesa MJ, et al. Polymorphism of the tlr4 gene reduces the risk of hepatitis c virus-induced hepatocellular carcinoma. Oncology 2012;82:35–40
  • Sajadi SM, Mirzaei V, Hassanshahi G, et al. Decreased expressions of toll-like receptor 9 and its signaling molecules in chronic hepatitis b virus-infected patients. Arch Pathol Lab Med 2013;137:1674–9
  • Mutlubas F, Mir S, Berdeli A, et al. Association between toll-like receptors 4 and 2 gene polymorphisms with chronic allograft nephropathy in Turkish children. Transplant Proc 2009;41:1589–93
  • Zhou TB. Signaling pathways of pax2 and its role in renal interstitial fibrosis and glomerulosclerosis. J Recept Signal Transduct Res 2012;32:298–303
  • Zhou TB. Signaling pathways of apoe and its role of gene expression in glomerulus diseases. J Recept Signal Transduct Res 2013;33:73–8
  • Zhou TB, Qin YH. The signaling pathways of lmx1b and its role in glomerulosclerosis. J Recept Signal Transduct Res 2012;32:285–9
  • Zhou TB, Qin YH. Signaling pathways of prohibitin and its role in diseases. J Recept Signal Transduct Res 2013;33:28–36

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.